366 related articles for article (PubMed ID: 16292454)
1. Ciclopirox nail lacquer 8% for the treatment of onychomycosis: a Canadian perspective.
Gupta AK; Schouten JR; Lynch LE
Skin Therapy Lett; 2005 Sep; 10(7):1-3. PubMed ID: 16292454
[TBL] [Abstract][Full Text] [Related]
2. Ciclopirox nail lacquer: a brush with onychomycosis.
Gupta AK
Cutis; 2001 Aug; 68(2 Suppl):13-6. PubMed ID: 11665723
[TBL] [Abstract][Full Text] [Related]
3. Ciclopirox nail lacquer topical solution 8%.
Gupta AK
Skin Therapy Lett; 2000; 6(1):1-5. PubMed ID: 11027420
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, open-label study of the efficacy and safety of ciclopirox nail lacquer solution 8% for the treatment of onychomycosis in patients with diabetes.
Seebacher C; Nietsch KH; Ulbricht HM
Cutis; 2001 Aug; 68(2 Suppl):17-22. PubMed ID: 11665724
[TBL] [Abstract][Full Text] [Related]
5. Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis.
Avner S; Nir N; Henri T
J Dermatolog Treat; 2005; 16(5-6):327-30. PubMed ID: 16428154
[TBL] [Abstract][Full Text] [Related]
6. The dermatopharmacologic profile of ciclopirox 8% nail lacquer.
Bohn M; Kraemer K
J Am Podiatr Med Assoc; 2000; 90(10):491-4. PubMed ID: 11107709
[TBL] [Abstract][Full Text] [Related]
7. Ciclopirox (Penlac) nail lacquer for onychomycosis.
Med Lett Drugs Ther; 2000 Jun; 42(1080):51-2. PubMed ID: 10859733
[No Abstract] [Full Text] [Related]
8. Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy.
Baran R; Kaoukhov A
J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):21-9. PubMed ID: 15649187
[TBL] [Abstract][Full Text] [Related]
9. A-Detail fact sheet (Canada). Ciclopirox 8% nail lacquer (Penlac).
Skin Therapy Lett; 2005 Dec-2006 Jan; 10(10):suppl 1 p.. PubMed ID: 16518906
[No Abstract] [Full Text] [Related]
10. An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis.
Baran R; Tosti A; Hartmane I; Altmeyer P; Hercogova J; Koudelkova V; Ruzicka T; Combemale P; Mikazans I
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):773-81. PubMed ID: 19453778
[TBL] [Abstract][Full Text] [Related]
11. Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study.
Shemer A; Nathansohn N; Trau H; Amichai B; Grunwald MH
J Dermatol; 2010 Feb; 37(2):137-9. PubMed ID: 20175847
[TBL] [Abstract][Full Text] [Related]
12. Ciclopirox 8% nail lacquer topical solution for the treatment of onychomycosis in patients with diabetes: a multicenter, open-label study.
Brenner MA; Harkless LB; Mendicino RW; Page JC
J Am Podiatr Med Assoc; 2007; 97(3):195-202. PubMed ID: 17507527
[TBL] [Abstract][Full Text] [Related]
13. Ciclopirox nail lacquer solution 8% in the 21st century.
Gupta AK; Baran R
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S96-102. PubMed ID: 11051138
[TBL] [Abstract][Full Text] [Related]
14. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
Gupta AK
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of onychomycosis with ciclopirox nail lacquer: a case report.
Galitz J
Cutis; 2001 Aug; 68(2 Suppl):23-4. PubMed ID: 11665725
[TBL] [Abstract][Full Text] [Related]
16. Ciclopirox 8% nail lacquer in the treatment of onychomycosis of the toenails in the United States.
Gupta AK; Joseph WS
J Am Podiatr Med Assoc; 2000; 90(10):495-501. PubMed ID: 11107710
[TBL] [Abstract][Full Text] [Related]
17. Ciclopirox nail lacquer and podiatric practice.
Gupta AK; Malkin KF
J Am Podiatr Med Assoc; 2000; 90(10):502-7. PubMed ID: 11107711
[TBL] [Abstract][Full Text] [Related]
18. Congenital candidal onychomycoses: effective cure with ciclopirox olamine 8% nail lacquer.
Sardana K; Garg VK; Manchanda V; Rajpal M
Br J Dermatol; 2006 Mar; 154(3):573-5. PubMed ID: 16445808
[No Abstract] [Full Text] [Related]
19. Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent.
Subissi A; Monti D; Togni G; Mailland F
Drugs; 2010 Nov; 70(16):2133-52. PubMed ID: 20964457
[TBL] [Abstract][Full Text] [Related]
20. [Therapy with ciclopirox lacquer of onychomycoses caused by molds].
Ulbricht H; Wörz K
Mycoses; 1994; 37 Suppl 1():97-100. PubMed ID: 7854374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
